THORP CLAY purchased 27.9% of their position (5K shares) of PHASEBIO PHARMACEUTICALS INC on the open market
Open‑market purchase worth $18.0K — a significant purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/24/2020ACC: 0001169245-20-000107
Director10% Owner
Since Oct 2018
+5K
Net shares
Net buyer
$18.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
5K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3K
Price / share
$3.67
Trade value
$11.01K
% of position
16.7%
11/23/2020
17.94K→20.94K
Common Stock
Direct
Shares
+2K
Price / share
$3.50
Trade value
$7K
% of position
9.5%
11/24/2020
20.94K→22.94K
Total
Net shares
+5K
Net value
$18.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/23/2020 | P · Purchase | +3K | $3.67 | $11.01K | 16.7% | 17.94K | 20.94K |
| Common Stock Direct | 11/24/2020 | P · Purchase | +2K | $3.50 | $7K | 9.5% | 20.94K | 22.94K |
| Total | +5K | $18.01K | ||||||
Derivative Transactions0
No derivative transactions reported